IRβ, the β subunit of insulin receptor; PI 3-kinase, phosphoinositide 3-kinase; pNPP, p-nitrophenyl phosphate; PtdIns-3,4,5-P 3 , phosphatidylinositol 3,4,5-triphosphate; PTEN, phosphatase and tensin homolog deleted on chromosome 10 -1 -Abstract Menadione (vitamin K 3 ) has been shown to activate Erk in several cell lines.
Introduction
Vitamin K is a fat-soluble vitamin essential for the post-translational modification of proteins, including the coagulation factors II (prothrombin), VII, IX, X, and proteins C, S, and Z [1] . Two naturally occurring forms of vitamin K, phylloquinone (vitamin K 1 ) and menaquinone (vitamin K 2 ), act as coenzymes for γ-glutamyl carboxylase, which produces γ-carboxyglutamic acid (Gla) by carboxylating the side chain of glutamic acid [2] . Vitamin K 3 (menadione, 2-methyl-1,4-naphthoquinone) is a synthetic vitamin K congener that is not a co-factor for γ-glutamyl carboxylase. Menadione has been examined extensively for its inhibitory effect on the proliferation of tumor cells both in vivo and in vitro [3] [4] [5] [6] . Similarly to various quinones, menadione can be reduced in cells to produce the semiquinone radical, which may impair the cellular constituents directly or indirectly through production of reactive oxygen species. The 3-position of menadione is also expected to react on the sulfhydryl group of glutathione by the Michael-type addition mechanism [7, 8] . Thus, menadione produces oxidative stress on cells through its ability to undergo both redox cycling and conjugate formation. In support of the occurrence of oxidative stress, CHO cells showing resistance to menadione-induced cell death have been reported to exhibit increased concentrations of glutathione and cysteine [9] . On the other hand, some effects of naphthoquinone derivatives are considered to be independent of oxidative stress [10] [11] [12] .
Menadione has been shown to activate the Erk cascade [13] [14] [15] . Abdelmohsen et al. suggested that this action of menadione may be separated from the oxidative stress -3 - [12] . They showed that the prior treatment of cells with the antioxidant, N-acetyl cysteine, which prevents the effect of the redox cycler, 1,4-benzoquinone, did not attenuate the effect of menadione. They also showed that menadione had a minor effect on the cellular level of glutathione at the concentration at which it activates Erk. Recent studies have indicated that menadione induces phosphorylation and activation of Erk by activating EGF receptors (EGFR), because pharmacological inhibitors of the receptor tyrosine kinase attenuated menadione-induced activation of Erk [12, 15, 16] . This conclusion was confirmed by the results of EGFR desensitization [12] .
Menadione has been reported to inhibit protein tyrosine phosphatases in cell-free systems [15] [16] [17] . An analog of menadione has been shown to be a potent inhibitor of Cdc25 with minor effects on other protein tyrosine phosphatases [18] . The basis of these inhibitory effects is proposed to be the direct interaction of the compounds with the cysteine residue that plays an essential role in the process of tyrosine dephosphorylation [17, 19, 20] . Based on these observations, menadione is proposed to perturb the balance between the phosphorylation and dephosphorylation of EGFR leading to activation of the Erk cascade [12, 16] . The effect of menadione on the PI 3-kinase/Akt cascade has also been observed and thus attributed to the activation of EGFR in rat liver epithelial cells [12] .
In the present study, we showed that menadione activates Akt in Chinese hamster ovary cells. This effect was dependent on PI 3-kinase, but was refractory to inhibition of EGFR/tyrosine kinase. Our results indicated that one target of menadione is PTEN (phosphatase and tensin homolog deleted on chromosome 10), which -4 -hydrolyzes and inactivates the products of PI 3-kinase [21, 22] . We also observed that menadione inhibits the dephosphorylation of both serine and threonine residues of Akt in intact cells. These effects of menadione were considered the basis of the EGFR-independent activation of Akt. instructions. The glutathione beads were incubated with precision protease, and the cleaved proteins were stored at -80°C in Tris-buffered saline containing 1 mM dithiothreitol (DTT). His-tagged proteins were eluted from the Ni-CAM beads with 250 mM imidazole. The eluate was applied to a PD-10 column to remove imidazole before storage at -80°C.
Cell lines
Chinese hamster ovary cells expressing insulin receptors (CHO-IR cells) were kind gifts from Dr. Y. Ebina (Ehime University, Matsuyama, Japan) and were cultured in F12-Ham's medium supplemented with 10% fetal calf serum, 100 U/ml of penicillin G, and 100 µg/ml of streptomycin. PTEN-null PC3 cells were obtained from Dr. T.
Maehama (National Institute of Infectious Diseases, Tokyo, Japan) and maintained in -6 -DMEM supplemented with 10% fetal calf serum, 100 U/ml of penicillin G, and 100 µg/ml of streptomycin.
Immunoblotting
The cells were lysed in lysis buffer consisting of 25 mM Tris-HCl (pH 7.6), . The radioactivity in the PtdIns-3-P spot was determined using Fuji BAS2000 analyzer (Fuji, Tokyo, Japan).
Dephosphorylation of IRβ
After CHO-IR cells were starved of serum for 15 h, the medium was replaced with incubation buffer consisting of 130 mM NaCl, 4.7 mM KCl, 1 mM CaCl 2 , 1.2 mM The amount of p-nitrophenol produced was determined from the absorbance at 405 nm.
The pNPP phosphatase activity of PTEN was assayed in buffer consisting of 100 mM sodium acetate (pH 5.5), 135 mM NaCl, 50 ng/µl of bovine serum albumin, and 10 mM DTT. The reaction was allowed to proceed at 20°C for 15 hour before being stopped.
Results

Menadione activates Akt in CHO cells without activating EGF receptors
Treatment of CHO cells with menadione or insulin caused the phosphorylation of Akt on both the Ser-473 residue in the C-terminal hydrophobic motif and the Thr-308 residue in the activation loop (Fig. 1a) . The effects were inhibited completely by the PI 3-kinase inhibitors, wortmannin and LY294002 (Fig. 1a) . The oxidative stress may not play a major role in Akt activation because the potent redox cycler 1,4-benzoquinone (30 µM) did not cause marked activation of Akt (data not shown). In several cell lines, menadione has been shown to activate Erk by activating endogenous EGFR [12, 15, 16] . In contrast to these studies, a pharmacological inhibitor of EGFR (AG1478) showed no effect on menadione-induced Erk phosphorylation (Fig.   1b) . The phosphorylation of Akt was again unaffected by AG1478 (Fig. 1b) . These results indicated that EGFR does not function in CHO cells. In fact, treatment of the cells with EGF did not induce phosphorylation of Erk or Akt (Fig. 1b) . In a control -10 -experiment using PC12 cells, AG1478 inhibited the EGF-induced activation of both Erk and Akt (Fig. 1c) .
Menadione does not affect PI 3-kinase activity
The activity of PI 3-kinase is known to increase when tyrosine-phosphorylated proteins bind to the SH2 domains of its regulatory subunit [23] .
We have reported that a naphthoquinone derivative, shikonin, inhibits the ability of recombinant PTP1B to dephosphorylate both pNPP and the insulin receptor [24] . As menadione and its derivatives have been shown to inhibit some tyrosine phosphatases [15] [16] [17] , one possible explanation for the EGFR-independent activation of Akt is the inhibited dephosphorylation and increased activity of insulin receptors. The experiment shown in Fig. 2 was performed to examine this possibility. IRβ in insulin-treated cells was in a highly phosphorylated state (Fig. 2a) . The removal of insulin by washing the cells with acidified medium (pH 6.0) caused rapid dephosphorylation of IRβ. The rate of dephosphorylation was unchanged when the same experiment was performed in the presence of 30 µM menadione (Fig. 2b) . These results indicated that the rate of IRβ dephosphorylation is unaffected by menadione. Another explanation for the action of menadione is the receptor-independent activation of cellular PI 3-kinase. However, we could not detect the presence of the active complex of PI 3-kinase in menadione-treated cells (Fig. 3) . The insulin-induced activation of PI 3-kinase was again unaffected by menadione (Fig. 3) . These results indicated that neither the activation nor inactivation mechanisms of PI 3-kinase were influenced by menadione.
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Menadione inhibits PTEN and Cdc25A in cell-free systems
Akt in insulin-treated cells was in a highly phosphorylated state due to the accumulation of PtdIns-3,4,5-P 3 . When the PI 3-kinase activity in the cells was abruptly blocked by addition of wortmannin, the phosphorylation decreased gradually and disappeared almost completely after 5 min (Fig. 4a) . In cells treated with 30 µM menadione, the rate of dephosphorylation was markedly slowed (Fig. 4b) . One possible explanation for the decreased Akt dephosphorylation is that menadione inhibited the dephosphorylation and inactivation of PtdIns-3,4,5-P 3 . In the experiment shown in Fig.   4c , recombinant PTEN was incubated with 50 µM PtdIns-3,4,5-P 3 and the liberation of phosphate was determined by Malachite green assay. The results clearly show that the lipid phosphatase activity of PTEN is inhibited by menadione.
As PTEN possesses the signature motif HCXXGXXR present in enzymes with tyrosine phosphatase activity [22, 25] , we examined the effect of menadione on the pNPP (p-nitrophenyl phosphate) phosphatase activities of both PTEN and tyrosine phosphatases (Fig. 5) . The recombinant enzymes were incubated with the indicated concentrations of menadione, and the phosphatase reaction was started by addition of 5 mM pNPP. The activity of PTEN was inhibited by menadione with IC 50 value of 3 µM (Fig. 5a ). The value was lower than that required to inhibit the lipid phosphatase activity (Fig. 4c) . The difference may be due to the higher K m value of pNPP as a substrate of PTEN (>20 mM). The activities of specific tyrosine phosphatases, PTP1B, SHP-1, and SHP-2, showed no or lower sensitivity to menadione (Fig. 5b) . The activity of a -12 -dual-specificity phosphatase, Cdc25A, was effectively inhibited by menadione (Fig. 5a) in agreement with the results of previous studies [17, 26] . The inhibition under the experimental conditions (pH 5.5) showed a biphasic pattern; the activity halved at 1 µM menadione and abolished at 100 µM. When the experiment was performed at pH 8.0, the inhibition showed a monophasic pattern with IC 50 value of 5 µM (data not shown).
Another dual-specificity phosphatase, VHR, the active pocket of which is reported to be shallow and thus similar to PTEN [27] , was not inhibited at all (Fig. 5a ). Thus, menadione possesses some selectivity toward PTEN and Cdc25A relative to other protein tyrosine phosphatases. It has been reported that an analog of menadione (Cpd 5), which is expected to interact with the catalytic cysteine residues of the tyrosine phosphatases, inhibits both Cdc25A and VHR [18] . The difference in the detailed structure of the active pockets and/or the reactivity of the central cysteine residues may be the basis of the selectivity.
Menadione inhibits both PTEN and pAkt phosphatase in intact cells
In the experiment shown in Fig. 6 , PTEN-deficient PC3 cells were artificially transfected with myc-tagged Akt (myc-Akt). As expected, the transfected myc-Akt was highly phosphorylated, which was reduced gradually when PI 3-kinase activity in the cells was blocked by LY294002. The rate of dephosphorylation was partly inhibited by menadione, indicating that the PTEN-independent degradation of PtdIns-3,4,5-P 3 and/or the activities of Ser/Thr phosphatases that target Akt were inhibited directly or indirectly.
Transfection of flag-tagged PTEN (flag-PTEN) together with myc-Akt decreased -13 -pSer-473 and pThr-308, probably by catalyzing the breakdown of PtdIns-3,4,5-P 3 . The effect of flag-PTEN was inhibited by menadione, suggesting that menadione possesses the ability to inhibit PTEN in intact cells.
Discussion
In the present study, we showed that menadione activates Akt in CHO cells.
The effect may not be due to activation of PI 3-kinase because menadione did not produce the active complex of PI 3-kinase in the cells (Fig. 3) . As an alternative mechanism, we showed that menadione inhibits the lipid phosphatase PTEN in both cell-free and intact-cell systems ( Fig. 4c and 6 ). As the inhibition of PTEN is expected to induce accumulation of PtdIns-3,4,5-P 3 , it is not surprising that an inhibitor of the lipid phosphatase activates Akt. In contrast to our results in CHO cells, it is reported in several cell lines that menadione activates PI 3-kinase through the activation of EGFR.
In such cells, the inhibition of PTEN and the activation of PI 3-kinase are considered to act synergisticallly in the menadione-induced activation of Akt.
In CHO cells, an inhibitor of EGFR did not attenuate the menadione-induced activation of Akt (Fig. 1B) . Inhibition of PTEN is, however, not the sole mechanism of the EGFR-independent activation, because menadione decreased the rate of Akt inactivation even in cells lacking PTEN (Fig. 6) . Although the regulatory mechanism of Ser/Thr phosphatase that inactivates Akt is not fully understood, the results of the present study suggest that some tyrosine phosphatase is included in the regulation. The potent action of menadione on Akt may be based on both the accelerated activation -14 -through inhibition of PTEN and decelerated inactivation probably through inhibition of some tyrosine phosphatases.
PTEN has been shown to be reversibly inactivated by hydrogen peroxide in cell-free and intact-cell systems [28] [29] [30] . This effect of hydrogen peroxide accompanied the mobility shift of PTEN [28] . As quinones including menadione are expected to produce reactive oxygen species in intact cells, menadione may inhibit PTEN in a similar mechanism to hydrogen peroxide. However, we observed that 30 µM menadione activated Akt without causing the mobility shift of PTEN in CHO cells (data not shown).
Furthermore, a potent redox cycler 1,4-benzoquinone did not activate Akt in the cells (data not shown). Thus production of reactive oxygen species may not be the mechanism leading to the PTEN inactivation in the cells. Menadione has been suggested to inhibit Cdc25A by binding to the critical cysteine residue within the signature motif [17, 19, 20] . Menadione may inhibit PTEN in a similar mechanism.
Naphthoquinone derivatives, including menadione, have been examined extensively for their inhibitory effects on the proliferation of tumor cells both in vivo and in vitro. The mechanism of growth arrest has been attributed to inhibition of Cdc25, prolonged phosphorylation of Erk, and increased oxidative stress. One goal of these studies is the clinical use of naphthoquinone derivatives in cancer treatment. We reported that a naphthoquinone derivative, shikonin, inhibits both PTEN and protein tyrosine phosphatases [24] . In the present study, a simple 1,4-naphthoquinone derivative, menadione, was found to inhibit PTEN in both cell-free and intact-cell systems. PTEN is a tumor suppressor, mutation of which is observed in about 50% of glioblastoma, -15 -endometrial carcinoma, prostate carcinoma, and melanoma cases [25] . The cell lysates were subjected directly to Western blotting analysis with anti-PTEN or anti-myc. Similar results were obtained in a repeated experiment.
